Patent · US Active

Universal antibody libraries

US11674240B2 · kind B2 · utility

0Cited by
9References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 6, 2005
Grant dateJun 13, 2023
Priority date
Expiry dateDec 14, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/622
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Universal antibody libraries are described which are synthetic and derived from expressed human antibody sequences selected accordingly to certain criteria, for example, that the sequences are derived from naturally-occurring antibodies expressed in response to a certain antigen class (e.g., small molecule, polysaccharide, peptide, or protein) and having CDR regions engineered for optimal diversity. Methods for making and screening such libraries for isolating therapeutics suitable for treating disease are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.